Treatment of Plaque-type Psoriasis with Methotrexate plus Betamethasone
Phase 3
- Conditions
- Psoriasis VulgarisPsoriasis.
- Registration Number
- IRCT2016010312782N9
- Lead Sponsor
- Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients with Plaue type of Psoriasis with involvement above 10% of body; Age range15-65; No sensitivity to Methotrexate; No contraindication for Betamethasone use; No comorbidity with other Autoimmune diseases.
Exclusion criteria: Patients resume from participation in the study; Impossibility of follow up of the patient due to various reason; Use of other treatment method during the study; Receive of other drugs during the study; Occurrence of drugs adverse reactions.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Psoriasis Area Severity Index. Timepoint: Once any 2 Months. Method of measurement: Physical Examination.
- Secondary Outcome Measures
Name Time Method